Genetics of Mucosal Immunity
Mucosal immunity provides specialised immune defence at epithelial surfaces including the respiratory tract, gut, and urogenital tract. Genetic variants in secretory IgA production, mucosal innate immunity, and epithelial barrier genes influence protection against pathogens entering through mucosal surfaces.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Mucosal Immunity?
The mucosal immune system protects the body's epithelial barriers — sites where pathogens most commonly enter. Secretory IgA is the primary antibody at mucosal surfaces, produced by plasma cells in mucosal-associated lymphoid tissue (MALT). Innate mucosal defences include mucins, antimicrobial peptides (defensins), and pattern recognition receptors on epithelial cells. In the context of SARS-CoV-2, mucosal immune responses — particularly nasal and lung mucosal IgA — are important for preventing viral attachment and limiting upper respiratory tract infection. Genetic variants in mucosal immune genes may influence barrier susceptibility to viral entry and establishment.
Biological pathways commonly discussed in relation to Mucosal Immunity
Research into Mucosal Immunity and Barrier Defence has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Secretory Iga
Secretory IgA is produced by plasma cells and transported across epithelial surfaces. Variants in PIGR (polymeric immunoglobulin receptor) and IgA class-switching genes affect mucosal antibody levels.
Antimicrobial Peptides
Defensins (DEFB1, DEFA5) and other antimicrobial peptides are produced by epithelial cells and neutrophils. Variants may alter their expression and spectrum of antimicrobial activity.
Mucosal Innate
Epithelial toll-like receptors (TLR2, TLR3, TLR5) and NOD receptors sense pathogens at mucosal surfaces. Variants affecting these sensors may alter the epithelial innate immune response to pathogens.
Mucosal T Cells
Tissue-resident memory T cells (Trm) in mucosal tissues provide local adaptive immune surveillance. Variants in tissue homing receptors and cytokine genes may influence mucosal T-cell populations.
Key genes studied in relation to Mucosal Immunity
The following genes have been studied in relation to Mucosal Immunity and Barrier Defence. These genes span the biological pathways most commonly discussed in this area of research.
11 genes total studied in relation to Mucosal Immunity across the ChronicDNA dataset.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Mucosal Immunity. Each variant represents a position in the genome where individuals may carry different alleles.
23 variants total across genes studied in relation to Mucosal Immunity.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Mucosal Immunity.
This is not a diagnostic service. Genetic variants do not determine whether you have Mucosal Immunity, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Mucosal Immunity shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
What is mucosal immunity and why is it relevant to COVID-19?
Mucosal immunity provides immune defence at epithelial surfaces — including the nasal passages and lungs — where SARS-CoV-2 first establishes infection. Mucosal IgA antibodies may block viral attachment and limit initial viral load, influencing subsequent disease course.
Which genes are studied in relation to mucosal immunity?
Key genes include PIGR, DEFB1, DEFA5, MUC2, TLR3, TLR5, and FCGR3A. These cover secretory IgA transport, antimicrobial peptide production, and mucosal innate immune sensing.
What are defensins?
Defensins are small antimicrobial peptides produced by epithelial cells and immune cells that disrupt microbial membranes. Beta-defensin 1 (DEFB1) is constitutively expressed in the respiratory and gastrointestinal tracts. Variants in the DEFB1 promoter may affect baseline defensin levels.
How does mucosal immunity relate to Long COVID?
Persistent viral antigen in mucosal tissues may drive ongoing local immune activation contributing to Long COVID. Genetic variants affecting mucosal viral clearance mechanisms may influence whether viral components persist after acute infection.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Mucosal Immunity and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
11 genes · 23 variants analysed in relation to Mucosal Immunity